The CerS4 Enzyme: How Your Skin Builds Its Own Ceramides

By Daniel Boscaccy

The CerS4 Enzyme: How Your Skin Builds Its Own Ceramides - Unearth Organics

Quick answer: CerS4 is one enzyme involved in the skin's ceramide-building process. Tallow does not contain ceramides, and we do not claim it does. The argument is that it delivers lipid precursors the skin can recognize.

Your skin has six different ceramide synthase enzymes. Each one builds a specific type of ceramide, and each one requires a specific fatty acid chain length to do its job. CerS4, the isoform most relevant to barrier function, preferentially uses stearoyl-CoA, derived from stearic acid (C18:0), to produce dihydroceramides that are subsequently converted into Ceramide NS, one of the primary structural ceramides in your skin's lipid matrix (PMC8468445).

That's a dense sentence, so let's unpack it with an analogy that makes the mechanism clear.

The Kitchen and the Chef

Think of your skin barrier as a kitchen. The chef is CerS4. The recipe is the ceramide synthesis pathway. The finished dish is Ceramide NS, a structural lipid that forms the mortar between your skin cells. This kitchen has been operating since you were born. The chef is skilled. The recipe is proven. The equipment works.

The problem isn't the kitchen. The problem is the pantry.

After your mid-30s, your body delivers less stearic acid to the epidermis. This is part of the broader 30% decline in barrier lipid production documented in aging research (Ghadially et al., 1995). CerS4 is still present. The enzyme doesn't disappear with age. But without its preferred substrate, stearoyl-CoA, it can't manufacture the ceramides your barrier needs to stay intact.

Feeding your skin, in the most literal biochemical sense, means restocking that pantry. Not delivering a finished dish to the table. Giving the chef the specific ingredient the recipe calls for, and letting the existing machinery do the rest.

What CerS4 Actually Does

Ceramide synthases belong to a family of enzymes called LASS (longevity assurance) proteins. There are six isoforms in human skin (CerS1 through CerS6), each with distinct substrate preferences. CerS4 prefers acyl-CoA chains of 18 to 22 carbons in length, with stearoyl-CoA (C18) being its primary substrate. It also accepts arachidonoyl-CoA (C20) and behenyl-CoA (C22), but the C18 chain is where the bulk of its activity occurs.

The reaction itself: CerS4 acylates a sphingoid base (dihydrosphingosine) with stearoyl-CoA to form a dihydroceramide. That dihydroceramide is then desaturated by a separate enzyme to produce the final structural ceramide. The end product, Ceramide NS (non-hydroxy sphingosine), is one of the dominant ceramide species in the stratum corneum's lipid matrix.

What makes this relevant for skincare isn't the biochemistry in isolation. It's the substrate specificity. CerS4 doesn't accept just any fatty acid. It needs stearic acid, converted to its CoA-activated form. If the supply of stearic acid declines, CerS4 output declines. The mortar production drops. The barrier weakens.

Can Topically Applied Stearic Acid Feed This Pathway?

This is the most important question, and honesty requires a careful answer.

The direct conversion of topically applied stearic acid into stearoyl-CoA for CerS4 ceramide synthesis has not been confirmed by clinical trials. The specific pathway from "stearic acid lands on your skin" to "CerS4 picks it up and makes Ceramide NS" remains a theoretical model. A biochemically plausible one, supported by the enzyme's documented substrate specificity and the lipid's known presence in the stratum corneum, but theoretical.

What has been demonstrated is the broader capability of the skin to utilize exogenous lipids. Research shows that keratinocytes have active fatty acid transport systems, including fatty acid translocase, designed to take up external fatty acids. Published studies confirm that topically applied fatty acids can be elongated by the skin's own enzymes and incorporated into the stratum corneum lipid matrix in compromised skin (Berkers et al., 2017). Topical lipids have been shown to be taken up by keratinocytes, packaged into lamellar bodies, and secreted into the intercellular spaces to form mature lamellar bilayers.

There's also evidence that topically applied lipids activate PPARs (peroxisome proliferator-activated receptors), which stimulate the skin's own endogenous lipid production and keratinocyte differentiation. The skin isn't passive. It has the machinery to process external inputs.

So the honest framing is this: the skin's enzyme requires stearic acid. The skin has documented transport and processing systems for exogenous fatty acids. Tallow delivers stearic acid in abundance. The direct clinical confirmation of the complete topical-to-CerS4 pathway is pending, but every prerequisite step in the chain has independent support.

That's a stronger argument than claiming certainty where it doesn't yet exist. And it's how we think about formulation.

Why This Changes How You Think About Ceramides in Skincare

Most ceramide-labeled skincare products deliver synthetic ceramide analogs (pseudoceramides) to the surface. That's a fundamentally different approach than delivering the substrate the skin's own enzyme uses to build native ceramides internally. One approach works from the outside in. The other works from the inside out, leveraging existing biological machinery.

We'll cover the pseudoceramide distinction in detail in a separate article. For now, the key concept is this: your skin isn't a passive surface waiting for finished products. It's an active manufacturing system. The enzyme exists. The pathway exists. The bottleneck is supply.

If you have been addressing dryness and sensitivity with surface-level moisturizers and wondering why the results are temporary, this is why. You've been delivering finished dishes to a kitchen that already has a chef. The chef just needs ingredients.

What We Do Differently

This enzyme is why we built the formula around grass-fed beef tallow. Tallow from grass-fed, grass-finished cattle contains a high concentration of stearic acid, the CerS4 substrate. We source from Fatworks and Grass Roots Coop, and Daniel renders each batch from suet only (kidney fat, not trim fat) at low temperatures in our Ocala workshop.

Why suet specifically? Published data from the American Oil Chemists' Society shows that kidney fat contains approximately 29% stearic acid, compared to just 11% in subcutaneous (trim) fat. That's a nearly threefold difference in the specific fatty acid CerS4 is designed to use. The fat depot you source from determines whether the stearic acid supply is adequate.

Why low-temperature rendering? Research shows that rendering above 121 degrees C (250 degrees F) begins degrading heat-sensitive vitamins and oxidizing unsaturated fatty acids. At 135 degrees C, peroxide values roughly double (Limmatvapirat et al., 2021). Industrial RBD processing reaches 190-270 degrees C. We render well below 93 degrees C (200 degrees F), preserving the lipid profile the enzyme depends on.

Six ingredients. No water. No preservatives. Thirty to forty-five jars per batch. The kitchen-grade threshold: if Daniel wouldn't eat it, it doesn't go in the jar.

Related Reading

Sources